HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fahien, L. A. Articles by MacDonald, M. J. Search for Related Content PubMed PubMed Citation Articles by Fahien, L. A. Articles by MacDonald, M. J. Social Bookmarking                What's this?

The Succinate Mechanism of Insulin Release

¹ Department of Pharmacology, University of Wisconsin Medical School, Madison, Wisconsin
² Childrens Diabetes Center, University of Wisconsin Medical School, Madison, Wisconsin

Nutrient secretagogues can increase the production of succinyl-CoA in rat pancreatic islets. When succinate esters are the secretagogue, succinyl-CoA can be generated via the succinate thiokinase reaction. Other secretagogues can increase production of succinyl-CoA secondary to increasing -ketoglutarate production by glutamate dehydrogenase or mitochondrial aspartate aminotransferase followed by the -ketoglutarate dehydrogenase reaction. Although secretagogues can increase the production of succinyl-CoA, they do not increase the level of this metabolite until after they decrease the level of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA). This suggests that the generated succinyl-CoA initially reacts with acetoacetate to yield acetoacetyl-CoA plus succinate in the succinyl-CoA-acetoacetate transferase reaction. This would be followed by acetoacetyl-CoA reacting with acetyl-CoA to generate HMG-CoA in the HMG-CoA synthetase reaction. HMG-CoA will then be reduced by NADPH to mevalonate in the HMG-CoA reductase reaction and/or cleaved to acetoacetate plus acetyl-CoA by HMG cleavage enzyme. Succinate derived from either exogenous succinate esters or generated by succinyl-CoA-acetoacetate transferase is metabolized to malate followed by the malic enzyme reaction. Increased production of NADPH by the latter reaction then increases reduction of HMG-CoA and accounts for the decrease in the level of HMG-CoA produced by secretagogues. Pyruvate carboxylation catalyzed by pyruvate carboxylase will supply oxaloacetate to mitochondrial aspartate aminotransferase. This would enable this aminotransferase to supply -ketoglutarate to the -ketoglutarate dehydrogenase complex and would, in part, account for secretagogues increasing the islet level of succinyl-CoA after they decrease the level of HMG-CoA. Mevalonate could be a trigger of insulin release as a result of its ability to alter membrane proteins and/or cytosolic Ca²⁺. This is consistent with the fact that insulin secretagogues decrease the level of the mevalonate precursor HMG-CoA. In addition, inhibitors of HMG-CoA reductase interfere with insulin release and this inhibition can be reversed by mevalonate.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				M. J. MacDonald, A. D. Smith III, N. M. Hasan, G. Sabat, and L. A. Fahien Feasibility of Pathways for Transfer of Acyl Groups from Mitochondria to the Cytosol to Form Short Chain Acyl-CoAs in the Pancreatic Beta Cell J. Biol. Chem., October 19, 2007; 282(42): 30596 - 30606. [Abstract] [Full Text] [PDF]

				X. Ma, L. Fan, Y. Meng, Z. Hou, Y.-D. Mao, W. Wang, W. Ding, and J.-Y. Liu Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome Mol. Hum. Reprod., August 1, 2007; 13(8): 527 - 535. [Abstract] [Full Text] [PDF]

				M. J. MacDonald Synergistic Potent Insulin Release by Combinations of Weak Secretagogues in Pancreatic Islets and INS-1 Cells J. Biol. Chem., March 2, 2007; 282(9): 6043 - 6052. [Abstract] [Full Text] [PDF]

				G. A. Martens, Y. Cai, S. Hinke, G. Stange, M. Van de Casteele, and D. Pipeleers Glucose Suppresses Superoxide Generation in Metabolically Responsive Pancreatic {beta} Cells J. Biol. Chem., May 27, 2005; 280(21): 20389 - 20396. [Abstract] [Full Text] [PDF]

				M. J. MacDonald, L. A. Fahien, L. J. Brown, N. M. Hasan, J. D. Buss, and M. A. Kendrick Perspective: emerging evidence for signaling roles of mitochondrial anaplerotic products in insulin secretion Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E1 - E15. [Abstract] [Full Text] [PDF]

				A. Farret, M. Vignaud, S. Dietz, J. Vignon, P. Petit, and R. Gross P2Y Purinergic Potentiation of Glucose-Induced Insulin Secretion and Pancreatic Beta-Cell Metabolism Diabetes, December 1, 2004; 53(suppl_3): S63 - S66. [Abstract] [Full Text] [PDF]

				S. C. Gunawardana, Y.-J. Liu, M. J. MacDonald, S. G. Straub, and G. W. G. Sharp Anaplerotic input is sufficient to induce time-dependent potentiation of insulin release in rat pancreatic islets Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E828 - E833. [Abstract] [Full Text] [PDF]

				G. W. Cline, R. L. LePine, K. K. Papas, R. G. Kibbey, and G. I. Shulman 13C NMR Isotopomer Analysis of Anaplerotic Pathways in INS-1 Cells J. Biol. Chem., October 22, 2004; 279(43): 44370 - 44375. [Abstract] [Full Text] [PDF]

				N. H. Ertel Diabetes and Cholesterol Metabolism: The succinate hypothesis Diabetes Care, February 1, 2003; 26(2): 549 - 550. [Full Text]

				P. P. Simonen, H. Gylling, and T. A. Miettinen Diabetes and Cholesterol Metabolism: The succinate hypothesis Diabetes Care, February 1, 2003; 26(2): 550 - 550. [Full Text]